MediWound Ltd.
Status: Publicly traded
Direct answer
MediWound Ltd. is publicly traded on NASDAQ under the ticker MDWD.
MediWound Ltd., an Israeli biopharmaceutical company established in 2000 and based in Yavne, focuses on the innovation, production, and sale of advanced biological treatments for the healing and regrowth of damaged tissues. The company's key commercialized product is NexoBrid, a biological drug distributed to specialized burn centers and hospital burn units. NexoBrid is specifically formulated for the enzymatic...
Can you invest in MediWound Ltd.?
Yes. MediWound Ltd. is publicly traded on NASDAQ under the ticker MDWD.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for MediWound Ltd.
Detailed equity research is provided by MarketSnap.